Synapse - Alexander Shoushtari

Search Within

Alexander Noor Shoushtari

Results (244)

A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors

Journal Article

Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
Radiotherapy and Oncology (2024)

Fulltext@MSK | Save

Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study

Journal Article

Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma

Journal Article

Sacco, J. J.; Carvajal, R. D.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L.; Nathan, P.; Hamid, O.; Piulats, J. M.; more...
Journal for ImmunoTherapy of Cancer (2024)

Fulltext@MSK | Save

Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: A propensity score-weighted analysis

Journal Article

Piulats, J. M.; Watkins, C.; Costa-García, M.; del Carpio, L.; Piperno-Neumann, S.; Rutkowski, P.; Hassel, J. C.; Espinosa, E.; de la Cruz-Merino, L.; Ochsenreither, S.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors

Journal Article

Francis, J. H.; Barker, C. A.; Canestraro, J.; Abramson, D. H.; Shoushtari, A. N.
American Journal of Ophthalmology Case Reports (2024)

Fulltext@MSK | Save

The features and management of acquired resistance to PD1-based therapy in metastatic melanoma

Journal Article

Hepner, A.; Versluis, J. M.; Wallace, R.; Allayous, C.; Brown, L. J.; Trojaniello, C.; Gerard, C. L.; Jansen, Y. J. L.; Bhave, P.; Neyns, B.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

Three-year overall survival with tebentafusp in metastatic uveal melanoma

Journal Article

Hassel, J. C.; Piperno-Neumann, S.; Rutkowski, P.; Baurain, J. F.; Schlaak, M.; Butler, M. O.; Sullivan, R. J.; Dummer, R.; Kirkwood, J. M.; Orloff, M.; more...
New England Journal of Medicine (2023)

Fulltext@MSK | Save

Favorable toxicity and local control with ultrahypofractionated radiation therapy (UH-RT) for melanoma of the lower genital tract (LGT)

Meeting Abstract

Silver, B.; White, C.; Zhang, Z.; Shoushtari, A.; Leitao, M. M.; Williams, V. M.; Alektiar, K. M.; Kollmeier, M. A.
International Journal of Radiation Oncology, Biology, Physics (2023)

Fulltext@MSK | Save

Effect of subsequent therapies including checkpoint inhibitors on overall survival in a phase III randomized trial of tebentafusp in first-line metastatic uveal melanoma: Long-term follow-up

Meeting Abstract

Orloff, M.; Watkins, C.; Carvajal, R. D.; Shoushtari, A. N.; Sacco, J. J.; Schlaak, M.; Gama, J.; Butler, M. O.
Annals of Oncology (2023)

Fulltext@MSK | Save

BRAF mutation status does not impact outcomes with tebentafusp in advanced cutaneous melanoma

Meeting Abstract

Shoushtari, A. N.; Middleton, M. R.; Hamid, O.; Meier, F.; Bauer, T.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P.; Mauch, C.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save